Common Contracts
10 similar Services Agreement contracts by Dermavant Sciences LTD, Axovant Gene Therapies Ltd., Immunovant, Inc., Urovant Sciences Ltd.
EX-10.6 10 d587760dex106.htm EX-10.6 Execution Version AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • May 5th, 2020 • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of July 9 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Urovant Sciences GmbH (f/k/a Thalavant Sciences GmbH), a company with limited liability organized under the laws of Switzerland (“USG”), Urovant Sciences, Inc. (f/k/a Thalavant Sciences, Inc.), a corporation organized under the laws of the State of Delaware (“USI”), and Urovant Sciences Ltd. (f/k/a Thalavant Sciences Ltd.), an exempted limited company organized under the laws of Bermuda (“USL”, and together with USI and USG, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).
SERVICES AGREEMENTServices Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Immunovant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“ISG”), Immunovant, Inc., a corporation organized under the laws of the State of Delaware (“II”), and Immunovant Sciences Ltd., an exempted limited company organized under the laws of Bermuda (“ISL”, and together with ISG and II, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).
SERVICES AGREEMENTServices Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences GmbH., a company with limited liability organized under the laws of Switzerland (the “Service Provider”) and Immunovant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“ISG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • June 11th, 2019 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of June 10, 2019, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Axovant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“ASG”), Axovant Sciences, Inc. (f/k/a Roivant Neurosciences, Inc.), a corporation organized under the laws of the State of Delaware (“ASI”), and Axovant Gene Therapies Ltd. (f/k/a Axovant Sciences Ltd., f/k/a Roivant Neurosciences Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“ASL,” and together with ASI and ASG, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • June 11th, 2019 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of June 10, 2019, by and among Roivant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“Service Provider”) and Axovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“ASG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • May 24th, 2019 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences GmbH., a company with limited liability organized under the laws of Switzerland (the “Service Provider”) and Dermavant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“DSG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • December 20th, 2018 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “ Service Provider”), Dermavant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“DSG”), Dermavant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“DSI”), and Dermavant Sciences Ltd., an exempted limited company organized under the laws of Bermuda (“DSL”, and together with DSG and DSI, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • December 20th, 2018 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences GmbH., a company with limited liability organized under the laws of Switzerland (the “Service Provider”) and Dermavant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“DSG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • July 13th, 2018 • Urovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of July 9 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Urovant Sciences GmbH (f/k/a Thalavant Sciences GmbH), a company with limited liability organized under the laws of Switzerland (“USG”), Urovant Sciences, Inc. (f/k/a Thalavant Sciences, Inc.), a corporation organized under the laws of the State of Delaware (“USI”), and Urovant Sciences Ltd. (f/k/a Thalavant Sciences Ltd.), an exempted limited company organized under the laws of Bermuda (“USL”, and together with USI and USG, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • July 13th, 2018 • Urovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of July 9 2018, by and among Roivant Sciences, GmbH., a company with limited liability organized under the laws of Switzerland (the “Service Provider”) and Urovant Sciences GmbH (f/k/a Thalavant Sciences GmbH), a company with limited liability organized under the laws of Switzerland (“USG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
